US Stock MarketDetailed Quotes

TRAW Traws Pharma

Watchlist
  • 5.020
  • -0.315-5.90%
Close Dec 20 16:00 ET
  • 5.020
  • 0.0000.00%
Post 20:01 ET
15.19MMarket Cap-0.04P/E (TTM)

Traws Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-156.79%-11.48M
-119.42%-9.85M
2.62%-4.42M
-10.05%-17.93M
-14.06%-4.43M
-14.59%-4.47M
-6.55%-4.49M
-5.75%-4.54M
16.39%-16.29M
8.93%-3.88M
Net income from continuing operations
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
12.21%-4.74M
-5.62%-4.25M
-40.10%-5.78M
-17.33%-18.96M
-44.00%-5.42M
Depreciation and amortization
-60.00%2K
0.00%4K
33.33%4K
14.29%16K
0.00%4K
66.67%5K
0.00%4K
0.00%3K
0.00%14K
0.00%4K
Other non cash items
--0
----
----
----
----
----
----
----
----
----
Change In working capital
-3,422.11%-3.35M
-781.43%-4.56M
-75.14%222K
-120.28%-301K
-148.42%-582K
-107.98%-95K
-18.85%-517K
288.79%893K
141.30%1.48M
256.92%1.2M
-Change in receivables
-210,200.00%-2.1M
--0
--0
1,200.00%11K
--0
---1K
--0
1,100.00%12K
-111.11%-1K
-200.00%-1K
-Change in prepaid assets
135.89%375K
-122.45%-22K
131.54%76K
-450.22%-1.26M
-113.11%-72K
-388.67%-1.05M
111.02%98K
3.98%-241K
-143.21%-229K
62.91%549K
-Change in payables and accrued expense
-254.86%-1.56M
-702.51%-4.48M
-82.85%202K
-39.20%1.17M
-163.94%-454K
15.07%1.01M
-208.98%-558K
805.39%1.18M
149.44%1.93M
178.02%710K
-Change in other current assets
----
----
----
--0
--0
----
----
----
--9K
--0
-Change in other working capital
0.00%-57K
0.00%-57K
0.00%-56K
0.00%-226K
0.00%-56K
0.00%-57K
0.00%-57K
0.00%-56K
0.00%-226K
0.00%-56K
Cash from discontinued investing activities
Operating cash flow
-156.79%-11.48M
-119.42%-9.85M
2.62%-4.42M
-10.05%-17.93M
-14.06%-4.43M
-14.59%-4.47M
-6.55%-4.49M
-5.75%-4.54M
16.39%-16.29M
8.93%-3.88M
Investing cash flow
Cash flow from continuing investing activities
0
-14K
0
-14K
0
0
Net PPE purchase and sale
----
----
----
---14K
--0
----
----
----
--0
--0
Net business purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
----
----
---14K
--0
---14K
----
----
--0
--0
Financing cash flow
Cash flow from continuing financing activities
0
0
Net common stock issuance
--0
----
----
----
----
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
----
----
----
----
--0
----
----
----
----
Net cash flow
Beginning cash position
-43.20%16.89M
-52.10%16.39M
-46.28%20.82M
-29.62%38.76M
-40.76%25.24M
-36.11%29.73M
-32.59%34.22M
-29.62%38.76M
189.46%55.07M
-28.23%42.61M
Current changes in cash
-155.99%-11.48M
111.11%499K
2.62%-4.42M
-10.14%-17.95M
-14.06%-4.43M
-14.95%-4.48M
-6.55%-4.49M
-5.75%-4.54M
-145.17%-16.29M
9.67%-3.88M
Effect of exchange rate changes
--0
-200.00%-3K
-216.67%-7K
152.63%10K
-75.00%7K
90.00%-2K
95.00%-1K
185.71%6K
32.14%-19K
450.00%28K
End cash Position
-78.57%5.41M
-43.20%16.89M
-52.10%16.39M
-46.28%20.82M
-46.28%20.82M
-40.76%25.24M
-36.11%29.73M
-32.59%34.22M
-29.62%38.76M
-29.62%38.76M
Free cash flow
-155.99%-11.48M
-119.42%-9.85M
2.62%-4.42M
-10.14%-17.95M
-14.06%-4.43M
-14.95%-4.48M
-6.55%-4.49M
-5.75%-4.54M
16.39%-16.29M
8.93%-3.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -156.79%-11.48M-119.42%-9.85M2.62%-4.42M-10.05%-17.93M-14.06%-4.43M-14.59%-4.47M-6.55%-4.49M-5.75%-4.54M16.39%-16.29M8.93%-3.88M
Net income from continuing operations -78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M0.08%-18.95M22.80%-4.18M12.21%-4.74M-5.62%-4.25M-40.10%-5.78M-17.33%-18.96M-44.00%-5.42M
Depreciation and amortization -60.00%2K0.00%4K33.33%4K14.29%16K0.00%4K66.67%5K0.00%4K0.00%3K0.00%14K0.00%4K
Other non cash items --0------------------------------------
Change In working capital -3,422.11%-3.35M-781.43%-4.56M-75.14%222K-120.28%-301K-148.42%-582K-107.98%-95K-18.85%-517K288.79%893K141.30%1.48M256.92%1.2M
-Change in receivables -210,200.00%-2.1M--0--01,200.00%11K--0---1K--01,100.00%12K-111.11%-1K-200.00%-1K
-Change in prepaid assets 135.89%375K-122.45%-22K131.54%76K-450.22%-1.26M-113.11%-72K-388.67%-1.05M111.02%98K3.98%-241K-143.21%-229K62.91%549K
-Change in payables and accrued expense -254.86%-1.56M-702.51%-4.48M-82.85%202K-39.20%1.17M-163.94%-454K15.07%1.01M-208.98%-558K805.39%1.18M149.44%1.93M178.02%710K
-Change in other current assets --------------0--0--------------9K--0
-Change in other working capital 0.00%-57K0.00%-57K0.00%-56K0.00%-226K0.00%-56K0.00%-57K0.00%-57K0.00%-56K0.00%-226K0.00%-56K
Cash from discontinued investing activities
Operating cash flow -156.79%-11.48M-119.42%-9.85M2.62%-4.42M-10.05%-17.93M-14.06%-4.43M-14.59%-4.47M-6.55%-4.49M-5.75%-4.54M16.39%-16.29M8.93%-3.88M
Investing cash flow
Cash flow from continuing investing activities 0-14K0-14K00
Net PPE purchase and sale ---------------14K--0--------------0--0
Net business purchase and sale --0------------------0----------------
Cash from discontinued investing activities
Investing cash flow --0-----------14K--0---14K----------0--0
Financing cash flow
Cash flow from continuing financing activities 00
Net common stock issuance --0------------------0----------------
Cash from discontinued financing activities
Financing cash flow --0------------------0----------------
Net cash flow
Beginning cash position -43.20%16.89M-52.10%16.39M-46.28%20.82M-29.62%38.76M-40.76%25.24M-36.11%29.73M-32.59%34.22M-29.62%38.76M189.46%55.07M-28.23%42.61M
Current changes in cash -155.99%-11.48M111.11%499K2.62%-4.42M-10.14%-17.95M-14.06%-4.43M-14.95%-4.48M-6.55%-4.49M-5.75%-4.54M-145.17%-16.29M9.67%-3.88M
Effect of exchange rate changes --0-200.00%-3K-216.67%-7K152.63%10K-75.00%7K90.00%-2K95.00%-1K185.71%6K32.14%-19K450.00%28K
End cash Position -78.57%5.41M-43.20%16.89M-52.10%16.39M-46.28%20.82M-46.28%20.82M-40.76%25.24M-36.11%29.73M-32.59%34.22M-29.62%38.76M-29.62%38.76M
Free cash flow -155.99%-11.48M-119.42%-9.85M2.62%-4.42M-10.14%-17.95M-14.06%-4.43M-14.95%-4.48M-6.55%-4.49M-5.75%-4.54M16.39%-16.29M8.93%-3.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data